Qubit Pharmaceuticals

We are proud to announce that our latest research paper, "Polylogarithmic-depth controlled-NOT gates without ancilla qubits," has been published in Nature Communications (Nature Portfolio)! 👏 This work, led by our CSO and cofounder, Jean-Philip Piquemal, and his team, introduces a method for decomposing multi-control NOT gates into native quantum gates, achieving exponentially shorter circuits than previous methods. This breakthrough enhances the efficiency of quantum algorithms, with significant implications for fields such as quantum chemistry, physics, finance, and machine learning. In industries like #drugdiscovery and development, where the demand for computing power is ever-increasing, our advancements in quantum computing offer promising solutions. The frequency and quality of peer-reviewed publications in top-tier journals like Nature Communications highlight the exceptional standards and impact of our research - and we couldn't be prouder of the team. 🌟 Congratulations to Baptiste Claudon, Julien Zylberman, César Feniou, in collaboration with Fabrice Debbasch and Alberto Peruzzo, as well as, of course, Jean-Philip Piquemal. Our ongoing collaboration with Sorbonne Université and Centre national de la recherche scientifique continues to drive our research forward - bringing us yet one step closer to unlocking the power of quantum at scale to design better treatments for particularly complex targets. Read Jean-Philip's Blog for some 'behind the paper' insights: https://lnkd.in/ecmtCSuT Explore the full paper here: https://lnkd.in/e3-nKaj6 #QuantumComputing #DrugDiscovery #QuantumAlgorithms #NatureCommunications #QubitPharmaceuticals #ResearchAndDevelopment

📺 Qubit Pharma in the Media Yesterday morning our CEO Robert Marino was a guest in French News Show Good Morning Business on BFM Business, hosted by Laure Closier, to announce our recent breakthroughs in applied quantum computing research and the €8M in funding we've received as part of the #France2030 plan by the Secretary general for investment and the iDémo program by Bpifrance. If you missed it, you can watch it back here https://lnkd.in/dGQnT77g #France2030 #QuantumComputing #QuantumAidedDrugDesign

Today, we hosted our very first in-house press conference, where we were thrilled to share not only our latest news but also our vision of how expertly combining Quantum Computing, HPC, and AI/ML will drastically improve the in silico drug discovery process by introducing even more precision, speed, and efficiency into our calculations. We'd like to extend our gratitude to: ▶ Robert Marino, CEO at Qubit Pharmaceuticals, for sharing the current state of how these technologies integrate into today's drug discovery process. ▶ Christophe Jurczak, Managing Partner at Quantonation, for providing valuable insights into the quantum ecosystem from an investor's perspective. ▶ Sébastien Luttringer, Head of R&D at Scaleway, for presenting their current activities as one of Europe's leading cloud providers and their strategy on quantum computing, which has supported us in some of our latest projects. ▶ Jean-Philip Piquemal, our CSO and Director of the Laboratoire de Chimie Théorique at Sorbonne Université, for explaining our latest achievements with Hyperion-1 and the new qubit compression techniques he and his team have developed. It was a morning full of information and learning, and we feel energized by the interest we've received! #QuantumComputing #HPC #AI #DrugDiscovery #QubitPharmaceuticals #Innovation #PressConference Ulysse Communication Nicolas Daniels Eléonore de Rose James Martin Sarada Loock photo credit © Choukhri Dje

🚀 Major breakthrough in quantum algorithms: Qubit Pharmaceuticals and Sorbonne Université drastically reduce the number of qubits needed to simulate molecules - from over 250 to just 20! We're thrilled to announce that this achievement, powered by our Hyperion-1 emulator, has secured €8 million in funding from the France 2030 plan within the i-Démo programme, powered by Bpifrance and Secretary general for investment. 🌟 We'd like to thank all the partners involved - especially Sorbonne Université, Scaleway & GENCI - this milestone brings us closer to the practical application of hybrid HPC-quantum computing in drug discovery, reinforcing our goal to pioneer molecular modeling-based drug discovery. Find out all the details and statements in the press release below! #QuantumforPharma #QuantumComputing #DrugDiscovery #idemo

🇮🇹 Qubit Pharma, Italy & the Future of Pharmaceutical Research 🔬 We thank Quantum Italia for inviting us to speak at this great and insightful event on the impact of Quantum technologies on the future of pharmaceutical research 👏 Both our CEO Robert Marino and our Head of Quantum Computing, Alberto Peruzzo had a chance to present our vision for the future of drug discovery and our applied quantum research. They were impressed with the quality of the presentations and exchanges with guests and of course with fellow speakers Christophe Jurczak I Quantonation, Gabriele Morano & Simone De Liberato I Quantum Italia, Mauro D'Arcangelo I Pasqal, Martina Stella I Algorithmiq. We had a great time and we look forward to connecting again in the future! #QuantumItalia #DrugDiscovery #QuantumAidedDrugDesign

We're incredibly proud to share that following our nomination as member of the latest cohort of #TechnologyPioneers by the World Economic Forum, we're already attending the first event. Our COO Marion Pierfitte is currently attending the Annual Meeting of the New Champions of the WEF in Dalian, China. If you're there and want to meet with us - reach out to us or to Marion directly, we'd bee delighted to connect! 👏 #WEF24 #drugdiscovery #quantumaideddrugdesign

🌟 We're Hiring: Quantum Chemistry Data Engineer (M/F)! 🌟 Join our #HPQC team at Qubit Pharmaceuticals! We are looking for a talented Quantum Chemistry Data Engineer to enhance our Quantum Chemistry database and drive automated drug discovery. In this role, you'll: 🔸 Conduct and analyze quantum chemistry simulations 🔸 Develop and maintain our Python package QCDatasets 🔸 Collaborate with Machine Learning experts using cutting-edge hardware (>1000 CPUs, >100 GPUs) We're seeking a curious, autonomous, and collaborative engineer with strong analytical skills. At Qubit Pharmaceuticals, you'll join a cutting-edge team dedicated to drastically innovate the field of drug discovery. Benefit from a dynamic work environment, advanced technology, and the chance to make a significant impact on the future of healthcare. Don’t hesitate to apply even if you don’t fit 100% of the requirements—we're excited to get to know you! If you're not a fit right now, but think you might know someone that is, share this opportunity with your network and help us find the perfect fit. Visit our careers page to apply: https://lnkd.in/ecnHxu4S #QuantumChemistry #DataEngineering #HPQC #QubitPharmaceuticals #HiringNow

Qubit Pharmaceuticals is honored to be invited by Quantum Italia! 🇮🇹 Join us at "Le tecnologie quantistiche e il futuro della ricerca farmaceutica" ("Quantum Technologies and the Future of Pharmaceutical Research and Development") to explore the future of pharmaceutical R&D through quantum technologies, featuring insights on cost and time reduction using digital twins. Our CEO, Robert Marino, and our Head of Quantum computing, Alberto Peruzzo, have been invited to speak at this event, in recognition of our company's vision to unlock the power of quantum at scale to design novel molecules for complex targets. They will present their insights alongside outstanding speakers from prestigious Italian and international companies. 📅 June 27th, 2024 📍 HQ Scientifica Ventura Capital Please find all the details on how to attend in the link below! #QuantumComputing #Pharmaceuticals #QuantumItalia #QuantumforPharma #QuantumAidedDrugDesign

🌟 Join Qubit Pharmaceuticals as a Research Scientist! 🌟 Qubit Pharmaceuticals is looking for two Research Scientists (M/F) to help build our RNA platform as part of the project: "Targeting RNA and RNA-protein interactions using small molecules." This exciting role involves focusing on RNA and RNA/RBP complex structures and their interactions with small molecules. You'll use polarizable molecular dynamics simulations to understand these systems and free energy simulations to design effective ligand interactions. What We're Looking For: 🔹 Passion for the latest quantum technologies and state-of-the-art atomistic simulation methods. 🔹 Innovative problem-solving skills. 🔹 Strong team collaboration abilities. 🔹 Proactive and inquisitive nature. We need talented individuals who can bring new ideas to the table and are eager to apply them to very challenging systems, such as RNA and RBPs, to help design better drugs, faster! If you’re ready to contribute to impactful drug design projects and work with a pioneering team, apply now! 👉 Apply Here: https://lnkd.in/eMjsb3G8 #Hiring #ResearchScientist #DrugDesign #MolecularDynamics #QubitPharmaceuticals #JoinOurTeam

Our CEO, Robert Marino has co-signed an insightful op-ed alongside industry leaders, Loïc Henriet, CEO of Pasqal and Christophe Jurczak, Managing Partner at Quantonation, discussing the future of quantum computing in France and Europe. 🇫🇷🇪🇺 The article highlights the significant progress in the quantum industry, emphasizing how France and Europe have a unique opportunity to solidify their leadership in this groundbreaking field. Shortcut to full article here: https://lnkd.in/gimQK9pF Key points include: 🔹 The rapid transition of quantum computing from research to real-world applications, with promising developments across various sectors such as finance, chemistry, medicine, and energy. 🔹 The need for structured public-private partnerships and regional application centers to foster innovation, collaboration, and practical implementations of quantum technologies. Read more about how we can shape the future of quantum computing that will allow us to develop safer drugs, faster and design better treatments for any target and every patient. Read the article here: https://lnkd.in/gimQK9pF #QuantumComputing #Innovation #QuantumTechnology #Quantum4Bio